Genesis Emerging Markets Fund Limited
("the Fund")
30th October 2009
Results of Extraordinary General Meeting
The Board of the Fund announces that at the Extraordinary General Meeting held on 30th October 2009, the special
resolutions containing proposals for a share split, redenomination of share capital, amendments to the Memorandum and
adoption of new Articles of Incorporation were duly passed.
The Fund's participating shares will be redominated and commence trading in redenominated form on the London Stock
Exchange at 8.00 a.m. on 2nd November 2009.
Voting Rights and Capital
As of 2nd November 2009, the Fund's capital will consist of 134,963,060 ordinary shares with voting rights. Therefore,
the total number of voting rights in the Fund is 134,963,060.
The above figure (134,963,060) may be used by shareholders as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a change to their nterest in the Fund under the
FSA's Disclosure and Transparency Rules.
Results of Annual General Meeting
The Board also announces that all resolutions proposed at the Annual General Meeting of the Fund held on 30th
October 2009 were duly passed.
Changes of Director
As foreshadowed in the Fund's Annual Report, following the Annual General Meeting, Jeremy Paulson-Ellis has retired from
the Board with immediate effect. The Board wishes to express their gratitude to Mr. Paulson-Ellis for his contribution
to the strong reputation and continued success of the Fund.
Throughout his tenure as a Director, his extensive knowledge of - and long experience in - developing countries has
enabled him to act as a source of invaluable advice and guidance.
The Board is pleased to announce the appointment of Dr. John Llewellyn as a Director effective immediately following the
Annual General Meeting, subject to regulatory consent. Dr. Llewellyn is the founder of Llewellyn Consulting, a
London-based consultancy specialising in macroeconomics and environmental economics. From 1995 to 2008 he was Global
Chief Economist and then Senior Economic Policy Advisor at Lehman Brothers. Previously he spent seventeen years at the
OECD in Paris: in charge of international economic forecasting and policy analysis and, latterly, as Head of the
Secretary-General's Private Office (Chief of Staff). Prior to that Dr. Llewellyn spent ten years in academia (University
of Cambridge).
Enquiries
Angus Gordon Lennox / William Simmonds - 020 7588 2828
J.P. Morgan Cazenove
Coen Teulings (Chairman) - 020 7201 7200
Genesis Emerging Markets Fund Limited
Jonathan Snow - 020 7201 7200
Genesis
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.